CNTNAP1 and chronic inflammatory demyelinating polyradiculoneuropathy: The presence of autoantibodies against the CNTN1 or CNTN1/CASPR complex in CIDP patients suggests that these could play a pathogenic role, and for this reason, they could serve as diagnostic biomarkers in these patients [88,90].